google.com
Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr RSS 摘要
第一時間掌握 Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr 的最新更新。
最新貼文
在慣用的閱讀工具中取得 Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr
類似的 RSS 摘要
-
Aprea Therapeutics News Releases ir.aprea.com
-
AbbVie News Center news.abbvie.com
- Latest Sanofi Press Releases and News | Sanofi sanofi.com
-
KFF Health News kffhealthnews.org
-
ClinicalTrials.gov: Atopic Dermatitis | Last update posted in the last 14 days clinicaltrials.gov
-
Recently Published Human Medicines hma.eu
-
Public Health Agency of Canada - Updates canada.ca
-
EC Decisions concerning medicinal products ec.europa.eu
問題
Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr 的 RSS 摘要網址是什麼？
摘要網址是 https://www.google.com/alerts/feeds/11317382618987300685/7968218245088029816。將它貼到任何 RSS 閱讀器，或點選「立即追蹤」以在 Feeder 中閱讀。
Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr 多久發布一次文章？
Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr 的發文頻率為 每天約 3 次。 上一篇文章發布於 about 16 hours前。
Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr 的 RSS 摘要是否正常運作？
是。Feeder 於 4 minutes前檢查過，摘要回應正常。
Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr 的內容主題是什麼？
Feeder 將其歸類於 健康。
如何在 Feeder 中追蹤 Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr？
點選「立即追蹤」；如果還沒有帳號，請先註冊。 Feeder 的免費方案最多可訂閱 200 個動態消息來源，並可在網頁、iPhone 和 Android 上使用。無需信用卡。
在 Feeder 中追蹤 Google Alert - (“biosimilar” OR “biosimilars” OR “biobetter”) AND (“adalimumab” OR “ABP-501” OR “ABP501” OR “Amjevita” OR “Amgevita” OR “SB5” OR “Imraldi” OR “Hadlima” OR “BI 695501” OR “BI695501” OR “Cyltezo” OR “GP2017” OR “GP-2017” OR “Hefiya” OR “Hyr
Feeder 的免費方案最多可訂閱 200 個動態消息來源，並可在網頁、iPhone 和 Android 上使用。無需信用卡。